Robert J. Heine
Eli Lilly (United States) · 433 works · 44,148 citations · h-index 102
Top works
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
- Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria
- Translating the A1C Assay Into Estimated Average Glucose Values
- Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
- Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.
- Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study
- Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality
- Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study
- Impaired Fasting Glucose and Impaired Glucose Tolerance
- Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study
- Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes
- Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
- Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study
- Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects
- Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis
- Human insulin and hypoglycaemia
- Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes Who Are Not Using Insulin
- Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn Study
- Insulin and Risk of Cardiovascular Disease
- Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study